Vi-CRM197

CRM197-conjugated Vi polysaccharide vaccine · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vi-CRM197, covering 2014-03-24 to 2014-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults [Phase 2]